z-logo
open-access-imgOpen Access
Functional Pentameric Formation via Coexpression of the Escherichia coli Heat-Labile Enterotoxin B Subunit and Its Fusion Protein Subunit with a Neutralizing Epitope of ApxIIA Exotoxin Improves the Mucosal Immunogenicity and Protection against Challenge by Actinobacillus pleuropneumoniae
Author(s) -
Jung-Mi Kim,
Seung-Moon Park,
Jung-Ae Kim,
JinAh Park,
MinHee Yi,
Nan-Sun Kim,
Jong-Lye Bae,
Sung Goo Park,
YongSuk Jang,
MoonSik Yang,
DaeHyuk Kim
Publication year - 2011
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.05230-11
Subject(s) - fusion protein , heat labile enterotoxin , enterotoxin , immunogenicity , escherichia coli , epitope , recombinant dna , biology , protein subunit , microbiology and biotechnology , pseudomonas exotoxin , antigen , enterotoxigenic escherichia coli , biochemistry , immunology , gene
A coexpression strategy inSaccharomyces cerevisiae using episomal and integrative vectors for theEscherichia coli heat-labile enterotoxin B subunit (LTB) and a fusion protein of an ApxIIA toxin epitope produced byActinobacillus pleuropneumoniae coupled to LTB, respectively, was adapted for the hetero-oligomerization of LTB and the LTB fusion construct. Enzyme-linked immunosorbent assay (ELISA) with GM1 ganglioside indicated that the LTB fusion construct, along with LTB, was oligomerized to make the functional heteropentameric form, which can bind to receptors on the mucosal epithelium. The antigen-specific antibody titer of mice orally administered antigen was increased when using recombinant yeast coexpressing the pentameric form instead of recombinant yeast expressing either the LTB fusion form or antigen alone. Better protection against challenge infection withA. pleuropneumoniae was also observed for coexpression in recombinant yeast compared with others. The present study clearly indicated that the coexpression strategy enabled the LTB fusion construct to participate in the pentameric formation, resulting in an improved induction of systemic and mucosal immune responses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom